Home›Companies›Biotech & Pharma›Alpha Cognition

Alpha Cognition Inc.

Develops and sells medicines for people with Alzheimer's disease and other neurological conditions.

Updated Nov 19, 2026·Latest SEC filing Oct 9, 2024·Suggest an edit

About Alpha Cognition

Alpha Cognition is a private company based in Vancouver, British Columbia, Canada. It has reported $25,772,211 raised in 14 offerings on Form D since April 2016. Its chief executive is Michael McFadden.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 24, 2024Oct 9, 2024$4,545,000of $11.1M target22$206KEquity, Debt, Options, Securities on exercise, Senior Convertible Note Offering with Initial Warrants for Common Stock at price of $0.4220 per share equal to Note amount and Additional Warrants for Common Stock at price of $0.4220 per share equal to 50% of Note amount, exercisable until 9/24/2029Rule 506(b)Form D ↗
Jan 24, 2024Jan 31, 2024$2,839,628of $6.8M target60$47,327Equity, Options, Securities on exercise, Units, each comprised of one common share and one share purchase warrant, with each warrant having an exercise price of $0.31 and a term of three yearsRule 506(b)Form D ↗
Dec 22, 2023Jan 5, 2024$1,762,097of $4.2M target30$58,737Equity, Options, Securities on exercise, Units, each comprised of one common share and one share purchase warrant, with each warrant having an exercise price of $0.31 and a term of three yearsRule 506(b)Form D ↗
Nov 8, 2023Nov 20, 2023$1,009,999of $1.7M target13$77,692Equity, Options, Securities on exercise, Units, each comprised of one common share and one-half of a share purchase warrant, with each whole warrant having an exercise price of $0.31 and a term of three yearsRule 506(b)Form D ↗
Oct 16, 2023Oct 19, 2023$343,999of $586K target9$38,222Equity, Options, Securities on exercise, Units, each comprised of one common share and one-half of a share purchase warrant, with each whole warrant having an exercise price of $0.31 and a term of three yearsRule 506(b)Form D ↗
Aug 31, 2023Sep 12, 2023$1,260,837of $2.1M target28$45,030Equity, Options, Securities on exercise, Units, each comprised of one common share and one-half of a share purchase warrant, with each whole warrant having an exercise price of $0.31 and a term of three yearsRule 506(b)Form D ↗
Mar 15, 2023Mar 28, 2023$1,286,748of $3.2M target14$91,911Equity, Options, Securities on exercise, Units, each comprised of one common share and one share purchase warrant with an exercise price of C$0.39 and a term of five years.Rule 506(b)Form D ↗
Feb 16, 2023Feb 28, 2023$1,847,827of $4.6M target8$230KEquity, Options, Securities on exercise, Units, each comprised of one common share and one share purchase warrant with an exercise price of C$0.39 and a term of five years.Rule 506(b)Form D ↗
Oct 1, 2021Oct 18, 2021$424,983of $920K target3$141KEquity, Options, Securities on exercise, Units, each comprised of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at C$1.75 for 2 years.Rule 506(b)Form D ↗
Apr 27, 2020May 1, 2020$1,915,000fully sold9$212KDebt, Options, Securities on exercise, 5% Convertible notes and underlying common shares and common shares purchase warrants; warrants exercisable October 30, 2020Rule 506(b)Form D ↗
Aug 30, 2019Oct 9, 2019$5,951,093fully sold14$425KEquityRule 506(b)Form D ↗
Jul 5, 2018Jul 20, 2018$2,000,000of $4.0M target6$333KDebt, Options, Securities on exercise, 10% Convertible notes and underlying common shares and common share purchase warrants; warrants exercisable for 5 yearsRule 506(b)Form D ↗
Feb 28, 2017Dec 19, 2017$200,000fully sold1$200KEquity, Class A Common SharesRule 506(b)Form D ↗
Apr 4, 2016Apr 26, 2016$385,000fully sold1$385KEquity, Class A CommonRule 506(b)Form D ↗
Total, 14 offerings$25,772,211

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Alpha Cognition's Form D filed Oct 9, 2024.

LA
Lauren D'Angelo
Chief Operating Officer
First appears on the Form D that Alpha Cognition filed on October 18, 2021; on 10 of its 15 filings.
LM
Len Mertz
Director
On every Form D that Alpha Cognition has filed: 15 filings, from Apr 26, 2016 to Nov 18, 2024.
Len Mertz appears on 17 Form D filings at 2 companies. Show all
  • Neurodyn Life Sciences, neurodyn cognition inc and director: Oct 16, 2015
  • Alpha Cognition, director: Apr 26, 2016 · Dec 19, 2017 · Jul 20, 2018 · Oct 9, 2019 · May 1, 2020 · Dec 28, 2020 · Oct 18, 2021 · Feb 28, 2023 · Mar 28, 2023 · Sep 12, 2023 · Oct 19, 2023 · Nov 20, 2023 · Jan 5, 2024 · Jan 31, 2024 · Oct 9, 2024 · Nov 18, 2024
JH
John Havens
Director
First appears on the Form D that Alpha Cognition filed on October 9, 2019; on 13 of its 15 filings.
MM
Michael McFadden
CEO and Director
First appears on the Form D that Alpha Cognition filed on October 18, 2021; on 10 of its 15 filings.
JY
Jay Yoo
Executive officer
First appears on the Form D that Alpha Cognition filed on October 9, 2024; on 1 of its 15 filings.
RB
Rajeev Bakshi
Director
First appears on the Form D that Alpha Cognition filed on October 9, 2024; on 2 of its 15 filings.
PM
Phillip Mertz
Director
First appears on the Form D that Alpha Cognition filed on October 9, 2019; on 12 of its 15 filings.
KC
Kenneth Cawkell
Director and Founder
On every Form D that Alpha Cognition has filed: 15 filings, from Apr 26, 2016 to Nov 18, 2024.
Kenneth Cawkell appears on 26 Form D filings at 2 companies. Show all
  • Neurodyn Life Sciences, chief executive officer and director: Feb 6, 2013 (2 filings) · Apr 9, 2013 · Jun 12, 2013 · Sep 25, 2014 (2 filings) · Dec 8, 2014 (amended) · Mar 11, 2015 (amended) · Oct 16, 2015 · Nov 2, 2015
  • Alpha Cognition, director and founder: Apr 26, 2016 · Dec 19, 2017 · Jul 20, 2018 · Oct 9, 2019 · May 1, 2020 · Dec 28, 2020 · Oct 18, 2021 · Feb 28, 2023 · Mar 28, 2023 · Sep 12, 2023 · Oct 19, 2023 · Nov 20, 2023 · Jan 5, 2024 · Jan 31, 2024 · Oct 9, 2024 · Nov 18, 2024

Earlier filings also listed

  • Rob Bakshi · director
    Last listed on the Form D that Alpha Cognition filed on January 31, 2024; on 8 of its 15 filings.
  • Don Kalkofen · executive officer
    Last listed on the Form D that Alpha Cognition filed on January 31, 2024; on 7 of its 15 filings.
  • Denis Kay · executive officer
    Last listed on the Form D that Alpha Cognition filed on February 28, 2023; on 5 of its 15 filings.
    Denis Kay appears on 15 Form D filings at 2 companies. Show all
    • Neurodyn Life Sciences, executive officer and director: Feb 6, 2013 (2 filings) · Apr 9, 2013 · Jun 12, 2013 · Sep 25, 2014 (2 filings) · Dec 8, 2014 (amended) · Mar 11, 2015 (amended) · Oct 16, 2015 · Nov 2, 2015
    • Alpha Cognition, executive officer: Oct 9, 2019 · May 1, 2020 · Dec 28, 2020 · Oct 18, 2021 · Feb 28, 2023
  • Jeremy Wright · chief financial officer
    Last listed on the Form D that Alpha Cognition filed on October 18, 2021; on 1 of its 15 filings.
  • Jeremy Mertz · director
    Last listed on the Form D that Alpha Cognition filed on October 18, 2021; on 1 of its 15 filings.
  • Frederick Sancilio · director
    Last listed on the Form D that Alpha Cognition filed on October 18, 2021; on 3 of its 15 filings.
  • Anthony Giovinazzo · director
    Last listed on the Form D that Alpha Cognition filed on July 20, 2018; on 2 of its 15 filings.
  • Erich Mohr · director
    Last listed on the Form D that Alpha Cognition filed on December 19, 2017; on 2 of its 15 filings.

Sources

  1. SECAlpha Cognition Inc. filing history
  2. CompanyLegal
  3. CompanyAbout Alpha Cognition
  4. CompanyExecutive team
  5. CompanyBoard of directors